Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy. [electronic resource]
- American journal of hematology 08 2019
- E209-E213 p. digital
Publication Type: Letter; Research Support, N.I.H., Extramural
1096-8652
10.1002/ajh.25505 doi
Antigens, CD19--immunology Clinical Trials as Topic Disease Progression Female Humans Immunotherapy--methods Kaplan-Meier Estimate Lymphoma, Large B-Cell, Diffuse--immunology Male Middle Aged Receptors, Chimeric Antigen--immunology T-Lymphocytes--immunology